Molnupiravir
Antiviral medication
Molnupiravir ▸ Facts ▸ Comments ▸ News ▸ Videos
Molnupiravir, sold under the brand name Lagevrio among others, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Molnupiravir at 63/tablet soon: Hyderabad companiesIndiaTimes - Published | |
Pharma firms to roll out anti-Covid pill shortly as DCGI approves emergency useWith the Drugs Controller General of India (DCGI) approving the anti-Covid-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately..IndiaTimes - Published | |
Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortlyIndiaTimes - Published | |
Optimus Pharma to launch Covid-19 drug Molnupiravir shortlyIndiaTimes - Published | |
Bio E's Corbevax, SII's Covovax & antiviral drug Molnupiravir get EUA nodIn a significant boost for India’s fight against Covid-19, the Central Drugs Standard Control Organisation (CDSCO) has granted emergency use authorisation for two more Covid-19 vaccines – Corbevax..IndiaTimes - Published | |
Covid-19: Govt approves emergency use of Corbevax and Covovax vaccines and anti-viral pill MolnupiravirThe government on Tuesday announced that it has approved emergency use of two more Covid-19 vaccines - Corbevax and Covovax - and Molnupiravir, an anti-viral pill. With the nod from the government for..IndiaTimes - Published | |
BREAKING: Corbevax, Covovax, anti-viral drug Molnupiravir approved for emergency use in IndiaThe vaccines that have so far received emergency use authorisation have increased to 8, as of now.DNA - Published | |
USFDA nod to clear way for Molnupiravir use in IndiaIndiaTimes - Published | |
Govt panel to review EUA application for generic Covid-19 pillThe subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.IndiaTimes - Published | |
Covid: In a first, 5 Indian pharma majors join hands for Molnupiravir clinical trialsIndiaTimes - Published | |
MSN Labs begins Phase III trials of Molnupiravir on mild to moderate Covid-19 patientsIndiaTimes - Published |
